Harmonizing Development Internationally

Drug–Device

Designing Formulations Around Devices Rather Than Vice Versa

Pharma's Almanac

U.S. CDMO Capacity

More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand

Pharma's Almanac

Peptides

Enabling the Commercialization of Peptide Therapeutics with Manufacturing Advances

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Peptide Production

Peptide Manufacturing Enters the Industrial Era

David Alvaro, Ph.D.

Pharma's Almanac

Peptides

The Resurgence of Peptide Drugs in the Age of Precision Medicine

David Alvaro, Ph.D.

Pharma's Almanac

Greener TIDES

Greener Pathways for Peptide and Oligonucleotide Manufacturing

David Alvaro, Ph.D.

Pharma's Almanac

Spray Drying

From Formulation Tool to Manufacturing Strategy: The Evolving Role of Spray Drying

Nick Hodgson

Codis

Automation

Automation as a Strategic Enabler in Small Molecule Drug Development and Manufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Small Molecules

State of the Industry 2026 Virtual Panel: Small Molecules

Nice Insight

Continuous Mfg

Roundtable: Why the Future of Pharma Is Continuous

Salvatore Mascia, Ph.D.; Mark Bamforth; Andrea Semprini Cesari; William S. Marth; Alessandro Rollo

CONTINUUS Pharmaceuticals

API

What is driving renewed interest in small molecule therapeutics — and how is it shaping investment?

Pharma's Almanac